Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Open-Label Trial of Caspofungin Versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01307579
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:15.013643+00:00
Published At
2019-09-17T00:00:00+00:00
Record Updated At
2021-03-30
Results Posted At
2019-09-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Acute Myeloid Leukemia", "Adult Acute Monoblastic Leukemia", "Adult Acute Monocytic Leukemia", "Adult Acute Myeloid Leukemia in Remission", "Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11", "Adult Acute Myeloid Leukemia With Maturation", "Adult Acute Myeloid Leukemia With Minimal Differentiation", "Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11", "Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1", "Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A", "Adult Acute Myeloid Leukemia Without Maturation", "Adult Acute Myelomonocytic Leukemia", "Alkylating Agent-Related Acute Myeloid Leukemia", "Childhood Acute Monoblastic Leukemia", "Childhood Acute Monocytic Leukemia", "Childhood Acute Myeloid Leukemia in Remission", "Childhood Acute Myeloid Leukemia With Maturation", "Childhood Acute Myeloid Leukemia With Minimal Differentiation", "Childhood Acute Myeloid Leukemia Without Maturation", "Childhood Acute Myelomonocytic Leukemia", "Fungal Infection", "Myeloid Neoplasm", "Neutropenia", "Recurrent Adult Acute Myeloid Leukemia", "Recurrent Childhood Acute Myeloid Leukemia", "Secondary Acute Myeloid Leukemia", "Untreated Adult Acute Myeloid Leukemia", "Untreated Childhood Myeloid Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-03-30"
protocolSection.identificationModule.nctId
"NCT01307579"
protocolSection.identificationModule.officialTitle
"A Randomized Open-Label Trial of Caspofungin Versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-09-17"

Study condition terms

  • Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Adult Acute Monoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Adult Acute Monocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With Maturation (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With Minimal Differentiation (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia Without Maturation (protocolSection.conditionsModule.conditions)
  • Adult Acute Myelomonocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Alkylating Agent-Related Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Childhood Acute Monoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Childhood Acute Monocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Childhood Acute Myeloid Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • Childhood Acute Myeloid Leukemia With Maturation (protocolSection.conditionsModule.conditions)
  • Childhood Acute Myeloid Leukemia With Minimal Differentiation (protocolSection.conditionsModule.conditions)
  • Childhood Acute Myeloid Leukemia Without Maturation (protocolSection.conditionsModule.conditions)
  • Childhood Acute Myelomonocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Fungal Infection (protocolSection.conditionsModule.conditions)
  • Myeloid Neoplasm (protocolSection.conditionsModule.conditions)
  • Neutropenia (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Secondary Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Untreated Adult Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Untreated Childhood Myeloid Neoplasm (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.